Hyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits.
about
Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?Tetrahydrohyperforin Inhibits the Proteolytic Processing of Amyloid Precursor Protein and Enhances Its Degradation by Atg5-Dependent AutophagyAntidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.Hyperforin promotes mitochondrial function and development of oligodendrocytes.Reduced Alzheimer's disease pathology by St. John's Wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice.Spinosin, a C-Glucosylflavone, from Zizyphus jujuba var. spinosa Ameliorates Aβ1-42 Oligomer-Induced Memory Impairment in Mice.Up-regulation of P-glycoprotein reduces intracellular accumulation of beta amyloid: investigation of P-glycoprotein as a novel therapeutic target for Alzheimer's disease.How the Wnt signaling pathway protects from neurodegeneration: the mitochondrial scenarioPhloroglucinol Attenuates the Cognitive Deficits of the 5XFAD Mouse Model of Alzheimer's Disease.Complementary and alternative medicine use for treatment and prevention of late-life mood and cognitive disorders.Store-Operated Calcium Channel Complex in Postsynaptic Spines: A New Therapeutic Target for Alzheimer's Disease Treatment.Neurotrophic natural products: chemistry and biology.Dysregulation of neuronal calcium homeostasis in Alzheimer's disease - A therapeutic opportunity?The effect of hypericum perforatum on kidney ischemia/reperfusion damage.Tetrahydrohyperforin: a neuroprotective modified natural compound against Alzheimer's disease.Amyloid-beta-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Abeta peptide. Implications for the pathogenesis of Alzheimer's diseaseTetrahydrohyperforin prevents cognitive deficit, Aβ deposition, tau phosphorylation and synaptotoxicity in the APPswe/PSEN1ΔE9 model of Alzheimer's disease: a possible effect on APP processing.Apolipoprotein E3 (ApoE3) but not ApoE4 protects against synaptic loss through increased expression of protein kinase C epsilon.Profiling of hypothalamic and hippocampal gene expression in chronically stressed rats treated with St. John's wort extract (STW 3-VI) and fluoxetine.St. John's Wort reduces beta-amyloid accumulation in a double transgenic Alzheimer's disease mouse model-role of P-glycoprotein.Impact of origin and biological source on chemical composition, anticholinesterase and antioxidant properties of some St. John's wort species (Hypericum spp., Hypericaceae) from the Central Balkans.TRPC6 channel-mediated neurite outgrowth in PC12 cells and hippocampal neurons involves activation of RAS/MEK/ERK, PI3K, and CAMKIV signaling.Reduced TRPC6 mRNA levels in the blood cells of patients with Alzheimer's disease and mild cognitive impairment.The synergistic effect between KLVFF and self-assembly chaperones on both disaggregation of beta-amyloid fibrils and reducing consequent toxicity.TRPC Channels and Alzheimer's Disease.Dysregulation of Intracellular Calcium Signaling in Alzheimer's DiseaseNeurocognitive Improvement Through Plant Food Bioactives: A Particular Approach to Alzheimer’s Disease
P2860
Q21129335-A777517C-A4F3-408F-8731-DD429C69A2EAQ26859305-5E7EAC5F-6CC9-4C31-9DC1-7F3F4AD7C62FQ28547501-F73CA718-BECC-4848-B2D1-6AF157A5E0AEQ33751924-57339C42-1BDF-4C95-8446-B7DF59E227F3Q34208604-A9E6F0A7-B58F-44BB-9F96-916ED6162960Q34380018-E4921067-143B-4E5C-AFD5-18992748C232Q35161287-00CA734B-5D1E-45C3-95F4-24EB2A97B11BQ35184647-A44B6740-3F11-4AFB-950B-F330DA1611D0Q35569964-91D5154F-BA74-44AC-B33C-16AA8C75C28AQ35748709-83A79B0E-9B2B-4F71-B600-9B93B5BE7D07Q37409556-3D0A78A7-3DA1-4FF9-BA9D-D417C8AAC115Q37445085-E6546CA4-1B84-41C6-BBC0-C16F28751628Q37623342-13A446ED-624D-4B18-B3B6-56E6D6E7599DQ38958106-236502EF-EC23-458D-ADE4-A21970192722Q40331983-551DC2A6-0033-44BE-9748-1F393F5B0ADCQ40445320-14F2D798-F24E-44F2-8E8A-6503C05FE3D2Q41813709-BEC07D24-81AA-49F8-8D88-82BF407FBB62Q42046792-A14A1F2B-220C-4938-BEEA-53D1E71E24E1Q42084058-4CD05F70-7BF7-4B8C-BD49-61EF929458ACQ42868931-CA25E72F-3368-4F1B-9564-93C3795D2FD7Q44981842-8504DA58-23FB-4877-BAF5-EFAE86DD7BBEQ46989788-2F405863-515A-4484-B7B9-579B696C39BCQ47960200-7C592980-1F74-4173-92D1-5280B10B2D01Q48145375-67E9FC92-432C-4D47-9BAF-7DDF9D43704AQ50962551-893882F0-9103-4D91-9DF4-6F37A9647DE1Q50999462-2F780B10-1C16-47FB-9130-084544589C80Q57131389-27E9EFAA-C35D-45C2-A3C6-6DB46D7B1975Q59330523-36338099-B450-45AB-B1BF-AB986D423BE8
P2860
Hyperforin prevents beta-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-beta-deposits.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Hyperforin prevents beta-amylo ...... eimer's amyloid-beta-deposits.
@ast
Hyperforin prevents beta-amylo ...... eimer's amyloid-beta-deposits.
@en
Hyperforin prevents beta-amylo ...... eimer's amyloid-beta-deposits.
@nl
type
label
Hyperforin prevents beta-amylo ...... eimer's amyloid-beta-deposits.
@ast
Hyperforin prevents beta-amylo ...... eimer's amyloid-beta-deposits.
@en
Hyperforin prevents beta-amylo ...... eimer's amyloid-beta-deposits.
@nl
prefLabel
Hyperforin prevents beta-amylo ...... eimer's amyloid-beta-deposits.
@ast
Hyperforin prevents beta-amylo ...... eimer's amyloid-beta-deposits.
@en
Hyperforin prevents beta-amylo ...... eimer's amyloid-beta-deposits.
@nl
P2093
P2860
P356
P1433
P1476
Hyperforin prevents beta-amylo ...... eimer's amyloid-beta-deposits.
@en
P2093
J L Hancke
M C Dinamarca
N C Inestrosa
P2860
P2888
P304
P356
10.1038/SJ.MP.4001866
P407
P577
2006-07-25T00:00:00Z